Cannabis & Cannabinoids at AACAP Annual Meeting 2026
36 sessions on cannabis & cannabinoids · October 26–31, 2026, Atlanta, GA. Compare cannabis & cannabinoids at other meetings →
Tuesday, October 27
09:00–11:00 · Session · Clinical Perspectives
Cannabis Use and Early Psychosis Syndromes
Elizabeth Cohen · Hyun Jung Kim · Tushita Mayanil · Henry Teaford · Jeonghyun Shin
Clinical session on the relationship between cannabis use and early psychosis syndromes in youth.
09:00–11:00 · Lecture · Clinical Perspectives
Mary Jane 2.0: The Changing Face of Cannabis
Talk on how cannabis products and use patterns are changing, within a session on cannabis and early psychosis.
09:00–11:00 · Lecture · Clinical Perspectives
From High to Harm: Cannabis and the Neural Pathways Linked to Psychosis
Examines the neural pathways connecting cannabis use to psychosis risk.
09:00–11:00 · Lecture · Clinical Perspectives
Cannabis Use in Early Psychosis: Epidemiology, Risk Associations, and Evolving Practice Landscape
Covers epidemiology and risk associations of cannabis use in early psychosis and how clinical practice is evolving.
09:00–11:00 · Lecture · Clinical Perspectives
Mind the Gap: Examining the Intersection of Cannabis Policy and Early Psychosis
Jeonghyun Shin · Hyun Jung Kim
Looks at how cannabis policy interacts with early psychosis care and outcomes.
11:00–13:00 · Session · Clinical Perspectives
Out of the Fog: Managing Cannabis Withdrawal in Youth
Jesse Hinckley · Scott R. Hunter · Christopher Joseph Hammond · Alexander Chevalier · Laura A. Markley
11:00–13:00 · Lecture
High-Potency Tetrahydrocannabinol Product Use and Cannabis Withdrawal in Youth: New Clinical Challenges in a Shifting Legal Landscape
Looks at clinical challenges from high-potency THC products and cannabis withdrawal in youth as cannabis laws change.
11:00–13:00 · Lecture
Leveraging Motivational Strategies to Engage Youth With Cannabis Withdrawal
Covers motivational approaches for engaging young people experiencing cannabis withdrawal in care.
11:00–13:00 · Lecture
Beyond “Toughing It Out”: Practical Options for Managing Cannabis Withdrawal
Reviews practical management options for cannabis withdrawal.
11:00–13:00 · Lecture
When It’s More Than Withdrawal: Psychiatric Risk and Diagnostic Clarity in Adolescent Cannabis Withdrawal
Addresses psychiatric risk and diagnostic differentiation in adolescents with cannabis withdrawal.
13:30–15:30 · Lecture · Clinical Perspectives
Basic Science of Nicotine and Cannabis Interactions With Eating
Covers the basic science of how nicotine and cannabis interact with eating behavior and appetite.
Child & Adolescent · Eating Disorders · Neuroscience & Mechanisms
13:30–15:30 · Lecture · Clinical Perspectives
Comorbid Cannabis Use Disorder and Eating Disorders Among Youth: A 3-Year Analysis
Niranjan S. Karnik · Sara W. Kelly · Dale L. Smith
Presents a three-year analysis of co-occurring cannabis use disorder and eating disorders in youth.
Child & Adolescent · Eating Disorders · Substance Use Disorders
13:30–15:30 · Symposium · Clinical Perspectives
This Is Your Gut on Drugs: Eating Disorders and Gastrointestinal Problems Related to Nicotine and Cannabis Use
David L. Atkinson · Jennifer L. Derenne · Niranjan S. Karnik · Laura A. Markley · Jennifer Creedon
Clinical perspectives on how nicotine and cannabis use relate to eating disorders and gastrointestinal problems in young patients.
Child & Adolescent · Eating Disorders · Substance Use Disorders
Wednesday, October 28
10:30–12:30 · Lecture
When Cannabis Vaping Precipitates Psychosis: Clinical Lessons From Inpatient Youth Cases
Shares clinical lessons from inpatient youth cases in which cannabis vaping preceded psychosis.
10:30–12:30 · Lecture
Culture, Context, and Cannabis: Who Is Most at Risk for Psychosis?
Considers cultural and contextual factors that shape which youth are most at risk for cannabis-related psychosis.
Child & Adolescent · Diverse & Underserved Populations · Schizophrenia & Psychosis
10:30–12:30 · Lecture
From Hospital to Home: Continuity of Care After Cannabis-Induced Psychosis
Addresses continuity of care for adolescents after discharge following cannabis-induced psychosis.
Child & Adolescent · Collaborative & Integrated Care · Schizophrenia & Psychosis
10:30–12:30 · Session
From Potency to Psychosis: Innovating Clinical Care for Cannabis-Related Psychosis in Adolescents
Anton D. Livshin · Jesse Hinckley · Skylar Ackerman · Mansi Chandra · Christian Thurstone
10:30–12:30 · Lecture
Biology Behind the Break: How Cannabis Contributes to Psychotic Symptoms
Covers the biological mechanisms by which cannabis may contribute to psychotic symptoms.
Child & Adolescent · Neuroscience & Mechanisms · Schizophrenia & Psychosis
Posters (2)
- Dissociative Symptoms and Endocannabinoid Dysregulation in Adolescent PTSD — Armin Munir et al.
- Interaction of Cannabis and Family History of Psychosis Predicts Conversion to Psychosis at Long-Term Follow-Up in Clinical High-Risk Youth — Erick Regalado et al.
Thursday, October 29
Posters (5)
- Rising Substance Abstinence and Declining Cannabis Use Across Adolescence: National Trends, 2017–2024 — Sanobar Jaka et al.
- Neurocognitive Mechanisms Linking Adolescent Cannabis Use and Suicidal Behavior — Nadine Michel et al.
- Sleeping Off Adversity? Adverse-Positive Childhood Experience Profiles, Sleep Health, and Alcohol-Cannabis Co-Use Among Adolescents During the COVID-19 Pandemic — Austin D. Le et al.
- Cannabis Use in Adolescence Is Prospectively Associated With Reduced Cortical Thickness — Kevin H. Bao et al.
- Altered Resting-State Properties of Reward Expectancy and Reward Attainment Networks in Adolescent Cannabis Use and Depression — Tram N. Nguyen et al.
Friday, October 30
Posters (4)
- Adolescent Experiences of Reward, Cravings, and Cannabis Use During GLP-1 Treatment in a Pediatric Weight Management and Diabetes Program — Sanjana Baliga et al.
- Prenatal Co-Use of Cannabis and Tobacco and Placental Complication — Ajinkya Rai et al.
- Increasing Cannabis Use Among Adolescents With Depression Despite Stable National Trends, 2021-2024 — Tanner Bommersbach et al.
- Associations Between Medical and Recreational Cannabis Legalization and Serious Mental Illness in Young People Living in the United States — Christopher Joseph Hammond et al.
Saturday, October 31
12:30–14:30 · Lecture
Assessing Cannabinoid Receptor Alterations in Psychosis and Cannabis Use Through Postmortem Human Brain Samples and Rodent Models
Examines cannabinoid receptor changes in psychosis and cannabis use using postmortem human brain tissue and rodent models.
12:30–14:30 · Lecture
Adolescent Cannabis Use Escalation and Psychiatric Disorders Converge on Shared Neuronal Vulnerability Pathways
Explores shared neuronal vulnerability pathways linking escalating adolescent cannabis use and psychiatric disorders.
12:30–14:30 · Lecture
Long-Term Effects of Adolescent Vapor Exposure to Different Strains of Cannabis on Rat Adulthood Behavior and Brain Connectivity
Covers a rat study of how adolescent vaporized exposure to different cannabis strains affects adult behavior and brain connectivity.
12:30–14:30 · Lecture
Using Pharmacology to Balance Harm Reduction With Clinical Opportunity From Major and Minor Cannabinoids
Discusses cannabinoid pharmacology to weigh harm reduction against clinical potential of major and minor cannabinoids.
13:00–15:00 · Lecture
ADHD and Cannabis Use: Challenges in Diagnosis and Treatment
Discusses diagnostic and treatment difficulties when ADHD co-occurs with cannabis use.
Symposium · Symposium
Friend or Foe? The Complex Intersection Between Development, Cannabis, and Cannabinoid Pharmacology
Shinnyi Chou · Yasmin L. Hurd · Jeremy J. Watts · Jibran Khokhar · Rahul Nachnani
Symposium on cannabis and the developing brain, spanning cannabinoid pharmacology and developmental neuroscience, with addiction neurobiologist Yasmin Hurd.
Posters (1)
- Intersectionality of Cannabis Use and Suicide Risk in Youth — Andrea M. Horbey et al.
Other topics at this meeting
Child & Adolescent 1361Autism & Neurodevelopmental Disorders 272Diverse & Underserved Populations 231Practice, Policy & Workforce 171Psychotherapy 166Education & Training 156Digital Psychiatry & AI 149Measurement-Based Care & Diagnosis 145ADHD 135Neuroscience & Mechanisms 124PTSD & Trauma 114Suicide & Self-Harm 110